H. Waldmann et al.
FULL PAPER
CDCl3): d 73.29 (OCH2), 51.69 (NCH2), 32.00 (CH2-bridge), 30.11 (CH);
IR (drift): nÄ 3346 (NH), 2903, 2848 (Bohlmann-band),[11] 1559 (NH),
1456, 1415, 1326, 1264, 1198, and 1100 (OCH2), 853 cm 1; MS (70 eV); m/z
(m, 1H; OCH2CH); 13C NMR (125.8 MHz, CDCl3): d 150.16, 149.79,
132.80, 132.59, 131.32, 130.70 (arom. C), 130.14, 129.81, 128.32, 128.26,
126.97, 125.96, 125.93, 124.65, 124.46 (arom. CH), 123.89, 123.05 (arom. C),
122.41, 122.32 (arom. CH), 71.41, 71.05 (OCH2), 49.55, 47.18 (NCH2), 30.88
(CH2-bridge), 29.20, 29.07 (OCH2CH); 31P NMR (202.5 MHz, CDCl3) d
148.41; IR (drift): nÄ 3059, 2941, 2928, 2842 (Bohlmann-band),[11] 2185,
1921, 1825, 1590, 1504, 1463, 1327, 1233 (PO), 1207 (PO), 1070, 1063, 952,
826, 791, 756 cm 1; HR-FAB (3-NBA) calcd for C27H24N2O4P2: 442.1572,
found: 442.1588.
(%): 127 (72) [M ], 126 (13) [M
H], 106 (11), 96 (11), 94 (11), 83 (13), 82
(26) [M
C2H5O], 70 (13), 69 (11), 68 (23), 67 (23), 57 (16), 44 (100), 43
(53), 42 (29) [C2H4N ], 39 (19); HRMS (70 eV) calcd for C7H13NO:
127.0997, found: 127.0973.
General procedure for the synthesis of the C2-symmetric ligands 5 and 6: A
solution of (R)-1,1'-binaphthyl-2,2'-diol (1.29 g, 4.5 mmol) (4) in hot
toluene (50 mL)[2e] was added over a period of 30 min to a solution of
freshly destilled PCl3 (390 mL, 4.5 mmol) and NEt3 (1.32 mL, 9.5 mmol) in
toluene (8 mL) at 608C. The mixture was stirred for 2 h at 608C and
15 min at room temperature. After cooling to 408C a solution of the
bicyclic amine (1 or 3) (2 mmol) and NEt3 (0.63 mL, 4.5 mmol) in toluene
(2 mL) was added. The suspension was stirred at room temperature for two
days. After filtration through Celite and evaporation of the solvent under
reduced pressure the residue was purified by flash chromatography on
neutral alumina [2% NEt3 in n-hexane/CH2Cl2, 2:1 (v/v)].
General procedure for the addition of dialkylzinc reagents to cyclic enones
(9a, 9b, and 9c) in the presence of chiral ligands: A suspension of Cu(OTf)2
(11 mg, 0.03 mmol) and the phosphoramidite (0.033 mmol) in toluene/
CH2Cl2 6:1 (v/v) (3.5 mL) was stirred at room temperature for 1 h. The
suspension was cooled to the indicated temperature and the substrate
(1 mmol) was added. After addition of the dialkylzinc solution (1.2 mmol)
the resulting mixture was stirred at that temperature for 3 h. The solution
was poured onto saturated NH4Cl and extracted with diethyl ether (3 Â
20 mL). The combined organic layers were dried over Na2SO4 and the
solvent was carefully removed in vacuo. The residue was chromatographed
on silica gel to yield the corresponding ketone. The enantiomeric ratio of
9a and 9c was determined by gas chromatography (capillary column:
Machery&Nagel FS Lipodex E (0.25mm  50 m)). For ketone 9b the
corresponding acetal with (d)-( )-2,3-butanediol was used for GC analysis.
3,7-Bis[(R)-1,1'-binaphthyl-2,2'-dioxaphosphepinyl]-3,7-diazabicyclo[3.3.1]-
nonane (5): Yield: 0.85 g, 1.12 mmol, 56%; m.p. 2208C (decomp); [a]D20
698.5 (c 1, CHCl3); 1H NMR (500 MHz, CDCl3): d 8.01 (d, 3J
8.8 Hz, 2H; arom. CH), 7.95 (d, 3J 8.1 Hz, 2H; arom. CH), 7.89 ± 7.81
(m, 4H; arom. CH), 7.78 (d, 3J 8.8 Hz, 2H; arom. CH), 7.44 ± 7.33 (m, 8H;
arom. CH), 7.28 ± 7.17 (m, 6H; arom. CH), 3.58 ± 3.51 (m, 2H; NCH2eq),
3.39 (d, 2J 12.9 Hz, 2H; NCH2eq), 3.15 (d, 2J 15.7 Hz, 2H; NCH2ax), 2.45
(d, 2J 12.7 Hz, 2H; NCH2ax), 1.69 ± 1.67 (m, 2H; NCH2CH), 1.35 ± 1.33 (m,
2H; CH2-bridge); 13C NMR (100.6 MHz, CDCl3) d 150.49, 149.92,
132.94, 132.61, 131.30, 130.73 (arom. C), 130.15, 129.97, 128.32, 128.28,
127.03, 126.90, 126.04, 125.99, 124.71, 124.46 (arom. CH), 123.19, 122.37
(arom. C), 122.17 (arom. CH), 49.54, 49.11, 46.38, 46.11 (NCH2), 32.49
(CH2-bridge), 27.27 (NCH2CH); 31P NMR (202.5 MHz, CDCl3) d 148.06;
IR (drift): nÄ 3058, 2927, 2838 (Bohlmann band),[11] 1619, 1590, 1507, 1464,
3-Ethylcyclohexanone (9a) (Table 1, entry 3): Yield: 94%; 79% ee, R
enantiomer predominating; Rf 0.35 [pentane/diethyl ether, 7:1 (v/v)];
20
[a]D 16.0 (c 2.0, CHCl3, 79% ee) {ref. [12]: optical rotation positive
for R enantiomer}; 1H NMR (250 MHz, CDCl3): d 2.48 ± 2.18 (m, 3H),
2.12 ± 1.85 (m, 3H), 1.76 ± 1.55 (m, 2H), 1.43 ± 1.26 (m, 3H), 0.91 (t, 3J
9 Hz, 3H; CH3); GC (1008C, isothermal): tR 16.7 min [R enantiomer],
tR 17.4 min [S enantiomer].
3-Methylcyclohexanone (9b) (Table 1, entry 4): Yield: 91%; 81% ee, R
enantiomer predominating; Rf 0.40 [pentane/diethyl ether, 7:1 (v/v)];
[a]2D0 8.5 (c 2.5, CHCl3, 81% ee) {ref. [13]: [a]D28 11.7 (CHCl3 for R
1330, 1233 (PO), 1216 (PO), 1148, 1064, 978, 949, 824, 752, 696, 680,
1
617 cm
;
HR-FAB (3-nitrobenzyl alcohol (3-NBA)) calcd for
1
enantiomer)}; H NMR (250 MHz, CDCl3): d 2.42 ± 2.17 (m, 3H), 2.09 ±
C47H37N2O4P2: 755.2229, found: 755.2203.
1.80 (m, 4H), 1.76 ± 1.57 (m, 1H), 1.42 ± 1.25 (m, 1H), 1.03 (t, 3J 7 Hz, 3H;
CH3); GC (908C, isothermal, corresponding (d)-( )-2,3-butanediol acetal):
tR 15.6 min [S diastereomer], tR 15.9 min [R diastereomer].
1,5-Dimethyl-3,7-bis[(R)-1,1'-binaphthyl-2,2'-dioxaphosphepinyl]-3,7-di-
azabicyclo-[3.3.0]octane (6): Yield: 0.89 g, 1.16 mmol, 58%; m. p. 1688C;
[a]2D0
459.6 (c 1, CHCl3); 1H NMR (500 MHz, CDCl3): d 8.01 (d,
3J 8.8 Hz, 2H; arom. CH), 7.94 (d, 3J 8.1 Hz, 2H; arom. CH), 7.82 (d,
3J 8.1 Hz, 2H; arom. CH), 7.71 (d, 3J 8.8 Hz, 2H; arom. CH), 7.60 (d,
3J 8.7 Hz, 2H; arom. CH), 7.46 (d, 3J 8.5 Hz, 2H; arom. CH), 7.44 ± 7.40
(m, 6H; arom. CH), 7.37 (d, 3J 8.3 Hz, 2H; arom. CH), 7.32 ± 7.23 (m, 4H;
arom. CH), 3.27 (dd, 2J 10.6 Hz, 4J 2.7 Hz, 2H; NCH2), 3.01 (dd, 2J
10.6 Hz, 4J 5.2 Hz, 2H; NCH2), 2.97 (dd, 2J 10.5 Hz, 4J 3.1 Hz, 2H;
3-Methylcycloheptanone (9c) (Table 1, entry 6): Yield: 89%; 82% ee, R
enantiomer predominating; Rf 0.32 [pentane/diethyl ether, 10:1 (v/v)];
[a]2D0 60.9 (c 1.13, CHCl3, 82% ee) {ref. [14]: [a]2D5 55.2 (MeOH
1
for R enantiomer)}; H NMR (250 MHz, CDCl3): d 2.52 ± 2.40 (m, 4H),
1.96 ± 1.82 (m, 4H), 1.70 ± 1.57 (m, 1H), 1.49 ± 1.22 (m, 2H), 1.00 (t, 3J
9 Hz, 3H; CH3); GC (1008C, isothermal): tR 17.4 min [S enantiomer],
tR 18.1 min [R enantiomer].
2
4
NCH2), 2.69 (dd, J 10.5 Hz, J 3.7 Hz, 2H; NCH2), 0.87 (s, 6H; CH3);
13C NMR (125.8 MHz, CDCl3): d 149.88, 149.66, 132.86, 132.58, 131.37,
130.76 (arom. C), 130.29, 129.87, 128.38, 126.99, 126.92, 126.10, 126.08,
124.77, 124.54 (arom. CH), 123.93, 123.83 (arom. C), 122.12, 121.97 (arom.
CH), 57.13, 57.03, 56.90, 56.76 (NCH2), 50.46 (CCH3), 19.07 (CH3); 31P
NMR (202.5 MHz, CDCl3) d 148.63; IR (drift): nÄ 3055, 2967, 2870, 2410,
2183, 1904, 1619, 1591, 1507, 1464, 1328, 1232 (PO), 1205 (PO), 1066, 949,
824, 751, 697, 628 cm 1; HR-FAB (3-NBA) calcd. for C48H38N2O4P2:
769.2385, found: 769.2351.
General procedure for the addition of dialkylzinc reagents to acyclic
enones (11a and 11b) in the presence of chiral ligands
Method A: Addition of the zinc reagent to the catalyst/substrate mixture
(Table 2, entries 1 ± 3). A suspension of Cu(OTf)2 (11 mg, 0.03 mmol) and
the phosphoramidite (0.033 mmol) in toluene/CH2Cl2 (4:1; v/v) (4 mL) was
stirred at room temperature for 1 h. The substrate (1 mmol) was added and
the solution was cooled to 158C. After addition of the dialkylzinc
solution (1.5 mmol) the resulting mixture was stirred at that temperature
for 3 h. The suspension was poured onto 2m HCl (20 mL) and extracted
with diethyl ether (3 Â 30 mL). The combined organic layers were dried
over Na2SO4 and the solvent was removed in vacuo. The residue was
chromatographed on silica gel [n-hexane/ethyl acetate, 30:1 (v/v)] to yield
the corresponding 1,3-diphenyl ketone.
3-[(R)-1,1'-Binaphthyl-2,2'-dioxaphosphepinyl]-3-aza-7-oxa-bicyclo[3.3.1]-
nonane (7): A solution of (R)-1,1'-binaphthyl-2,2'-dioxaphosphorchloridite
(4)[10] (0.77 g, 2.2 mmol) in toluene (2 mL) was added at room temperature
to a solution of 3-aza-7-oxabicyclo[3. 3.1]nonane (2) (254 mg, 2 mmol) and
NEt3 (2.8 mL, 20 mmol) in toluene (2 mL). The resulting mixture was
stirred at 808C overnight. After filtration through Celite and evaporation
of the solvent under reduced pressure the residue was purified by flash
chromatography on Florisil deactivated by NEt3 [2% NEt3 in n-hexane/
CH2Cl2, 2:1 (v/v)]. Yield: 0.47 g, 1.06 mmol, 53%; m.p. 2498C (decomp);
Method B: Addition of the substrate to a catalyst/dialkylzinc mixture
(Table 2, entries 4 ± 6). A suspension of Cu(OTf)2 (11 mg, 0.03 mmol) and
the phosphoramidite (0.033 mmol) in toluene/CH2Cl2 (4:1; v/v) (4 mL) was
stirred at room temperature for 1 h. After cooling to 308C the dialkylzinc
solution (1.5 mmol) was added within 5 min. To this mixture was added
over a period of 1 h a solution of the substrate (1 mmol) in toluene/CH2Cl2
(4:1; v/v) (1 mL). The resulting solution was stirred at that temperature for
3 h. The isolation and purification of the product was achieved following
the procedure described above.
[a]2D0
503.3 (c 1, CH2Cl2); 1H NMR (500 MHz, CDCl3): d 7.96 (d,
3J 8.8 Hz, 1H; arom. CH), 7.92 ± 7.89 (m, 3H; arom. CH), 7.58 (d, 3J
8.8 Hz, 1H; arom. CH), 7.45 ± 7.39 (m, 4H; arom. CH), 7.35 (d, 3J 8.5 Hz,
2
1H; arom. CH), 7.30 ± 7.22 (m, 2H; arom. CH), 3.97 (d, J 11.1 Hz, 1H;
OCH2eq), 3.87 (d, 2J 11.1 Hz, 1H; OCH2eq), 3.75 (d, 2J 11.1 Hz, 1H;
2
OCH2ax), 3.65 (d, J 11.1 Hz, 1H; OCH2ax), 3.63 ± 3.58 (m, 1H; NCH2eq),
3.41 (d, 2J 12.7 Hz, 1H; NCH2eq), 3.30 (d, 2J 13.0 Hz, 1H; NCH2ax),
2.72 ± 2.66 (m, 1H; NCH2ax), 1.87 (d, 2J 12.4 Hz, 1H; CH2-bridge), 1.76 (d,
2J 12.4 Hz, 1H; CH2-bridge), 1.64 ± 1.61 (m, 1H; OCH2CH), 1.38 ± 1.35
Enantiomeric ratios were determined by HPLC (column: DAICEL
CHIRACEL OD, 0.2% iPrOH in n-hexane, flow rate 1.0 mLmin 1, UV
detector (255 nm)).
674
ꢀ WILEY-VCH Verlag GmbH, D-69451 Weinheim, 2000
0947-6539/00/0603-0674 $ 17.50+.50/0
Chem. Eur. J. 2000, 6, No. 3